A Novel Neurotrophic Drug for Cognitive Enhancement and Alzheimer's Disease
Open Access
- 14 December 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (12), e27865
- https://doi.org/10.1371/journal.pone.0027865
Abstract
Currently, the major drug discovery paradigm for neurodegenerative diseases is based upon high affinity ligands for single disease-specific targets. For Alzheimer's disease (AD), the focus is the amyloid beta peptide (Aß) that mediates familial Alzheimer's disease pathology. However, given that age is the greatest risk factor for AD, we explored an alternative drug discovery scheme that is based upon efficacy in multiple cell culture models of age-associated pathologies rather than exclusively amyloid metabolism. Using this approach, we identified an exceptionally potent, orally active, neurotrophic molecule that facilitates memory in normal rodents, and prevents the loss of synaptic proteins and cognitive decline in a transgenic AD mouse model.Keywords
This publication has 84 references indexed in Scilit:
- The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOENeurobiology of Aging, 2012
- The Aging Stress ResponseMolecular Cell, 2010
- Why Pleiotropic Interventions are Needed for Alzheimer's DiseaseMolecular Neurobiology, 2010
- Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: An investigation on the role of cellular stress response in the progression of Alzheimer diseaseBrain Research, 2010
- Inflammation, microglia, and alzheimer's diseaseNeurobiology of Disease, 2010
- Exercise and time-dependent benefits to learning and memoryNeuroscience, 2010
- Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetinGenes & Nutrition, 2009
- Exercise-induced improvement in cognitive performance after traumatic brain injury in rats is dependent on BDNF activationBrain Research, 2009
- A novel approach to screening for new neuroprotective compounds for the treatment of strokeBrain Research, 2007
- NEUROPROTECTIVE EFFECTS OF CURCUMINPublished by Springer Science and Business Media LLC ,2006